000890467 001__ 890467
000890467 005__ 20210623133424.0
000890467 0247_ $$2doi$$a10.1016/j.msard.2021.102744
000890467 0247_ $$2ISSN$$a2211-0348
000890467 0247_ $$2ISSN$$a2211-0356
000890467 0247_ $$2altmetric$$aaltmetric:97454472
000890467 0247_ $$2pmid$$a33517174
000890467 0247_ $$2WOS$$aWOS:000641391200027
000890467 037__ $$aFZJ-2021-00980
000890467 041__ $$aEnglish
000890467 082__ $$a610
000890467 1001_ $$0P:(DE-HGF)0$$aFilser, Melanie$$b0
000890467 245__ $$aMental symptoms in MS (MeSyMS): Development and validation of a new assessment
000890467 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2021
000890467 3367_ $$2DRIVER$$aarticle
000890467 3367_ $$2DataCite$$aOutput Types/Journal article
000890467 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1613046726_4129
000890467 3367_ $$2BibTeX$$aARTICLE
000890467 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000890467 3367_ $$00$$2EndNote$$aJournal Article
000890467 500__ $$aKein Post-print verfügbar!
000890467 520__ $$aBackgroundPatients with Multiple Sclerosis (MS) have an increased risk of suffering from mental and neuropsychiatric symptoms. So far, a fundamental problem in the clinical care of MS patients is that these symptoms are underdiagnosed and, as a consequence, often remain untreated. Present assessment tools have not been developed to be applied in patients with MS. This study aims to develop and validate a new questionnaire to identify disease-related mental symptoms in MS patients.MethodsA questionnaire has been developed by including the following subscales: social and emotional health problems, anxiety, and depression. To evaluate test quality and internal consistency, an item analysis has been conducted. After matching MS patients and control subjects on age and gender, we conducted group comparisons, a Receiver Operating Characteristic (ROC) Curve analysis and a binary logistic regression model.ResultsIn total, 314 MS patients and 100 matched control subjects were analysed. After performed item analysis, the questionnaire revealed an excellent internal consistency. Compared to control subjects, MS patients showed significant mental health problems in all three dimensions. In comparison to the subscales, the dimension of social and emotional health problems revealed the highest accuracy (AUC = 0.75; d = 0.948) and turned out to be the only scale that reliably differentiated between the groups.ConclusionsMeSyMS constitutes a valid screening instrument to detect mental symptoms in MS. Social and emotional health problems turned out to be the most important aspect when identifying disease-related mental health symptoms in MS.
000890467 536__ $$0G:(DE-HGF)POF4-525$$a525 - Decoding Brain Organization and Dysfunction (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000890467 588__ $$aDataset connected to CrossRef
000890467 7001_ $$00000-0002-1166-5214$$aBaetge, Sharon Jean$$b1
000890467 7001_ $$0P:(DE-HGF)0$$aBalloff, Carolin$$b2
000890467 7001_ $$00000-0003-4529-3444$$aBuchner, Axel$$b3
000890467 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon Rudolf$$b4$$ufzj
000890467 7001_ $$0P:(DE-HGF)0$$aHeibel, Markus$$b5
000890467 7001_ $$aMeier, Uwe$$b6
000890467 7001_ $$0P:(DE-HGF)0$$aRau, Daniela$$b7
000890467 7001_ $$0P:(DE-HGF)0$$aRenner, Alina$$b8
000890467 7001_ $$0P:(DE-HGF)0$$aSchreiber, Herbert$$b9
000890467 7001_ $$00000-0002-1102-1080$$aUllrich, Sebastian$$b10
000890467 7001_ $$0P:(DE-HGF)0$$aPenner, Iris-Katharina$$b11$$eCorresponding author
000890467 773__ $$0PERI:(DE-600)2645330-7$$a10.1016/j.msard.2021.102744$$gVol. 49, p. 102744 -$$p102744 -$$tMultiple Sclerosis and Related Disorders$$v49$$x2211-0348$$y2021
000890467 8564_ $$uhttps://juser.fz-juelich.de/record/890467/files/Filser_2021_Mult%20Scler%20Relat%20Dis_Mental%20symptoms%20in%20MS...-1.pdf$$yRestricted
000890467 909CO $$ooai:juser.fz-juelich.de:890467$$pVDB
000890467 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b4$$kFZJ
000890467 9130_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000890467 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000890467 9141_ $$y2021
000890467 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-08-25
000890467 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-08-25
000890467 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-08-25
000890467 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-08-25
000890467 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-08-25
000890467 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-08-25
000890467 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMULT SCLER RELAT DIS : 2018$$d2020-08-25
000890467 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-08-25
000890467 920__ $$lyes
000890467 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000890467 980__ $$ajournal
000890467 980__ $$aVDB
000890467 980__ $$aI:(DE-Juel1)INM-3-20090406
000890467 980__ $$aUNRESTRICTED